- PROTEASE ACTIVATED RECEPTOR 2 (PAR2) ANTAGONISTS
-
A compound of formula (I) or a pharmaceutically acceptable salt, solvate, hydrate thereof (I) Wherein Y, Z, R3, U, R4, m and n are as defined in the claims.
- -
-
Page/Page column 29-30
(2012/08/08)
-
- NOVEL JNK INHIBITORS
-
Disclosed are substituted imidazo[1,2-a]pyridines, imidazo[1,2-a]pyrazines, imidazo[1,2-c]pyrimidines and imidazo[1,2-d]triazines compounds of the formula: (1.0) Also disclosed are methods for treating JNK1 and ERK mediated diseases using the compounds of formula 1.0.
- -
-
Page/Page column 97; 98
(2008/12/07)
-